background preloader

Pharmaceutical Medicine - Pharmaceutics

Facebook Twitter

Database Access - UNSW Library. Early Biosimilar Development: A Model for Expeditious Progress to a Phase 3 Trial. Posted 01 March 2016 By Raymond Huml, MS, DVM, RAC, Nigel Rulewski, MD, Kamali Chance, MPH, PhD, RAC, Doris Weilert, PhD, J.

Early Biosimilar Development: A Model for Expeditious Progress to a Phase 3 Trial

Rick Turner, PhD This article discusses biosimilar clinical development and how companies are addressing the clinical development concerns associated with early biosimilar drug development. Combating Counterfeit Medicines: Legal Frameworks and Emerging Technologies. Posted 18 May 2016 By Bernard D.

Combating Counterfeit Medicines: Legal Frameworks and Emerging Technologies

Naughton, Sue Dopson, Stephen R. Chapman, David A. Brindley This article discusses the global problem of drug counterfeiting, reviews legal and manufacturing requirements imposed in the EU and US to protect against it and devices aimed at detecting counterfeit drugs. Regulatory One: Regulatory Agencies- Websites. North American Regulatory Agencies Health Canada, Canada European Regulatory Agencies EMA, Europe EDQM, Europe AFSSAPS, France BfArM, Germany AGES, Austria.

Regulatory One: Regulatory Agencies- Websites

Laetus Track and Trace Pha. Database Access - UNSW Library. Database Access - UNSW Library. Database Access - UNSW Library. Database Access - UNSW Library. Fermentation and Biochemical Engineering Handbook - Principles, Process Design, and Equipment (3rd Edition) - Knovel. Strategies to Modify the Drug Release from Pharmaceutical Systems - Knovel. Database Access - UNSW Library. Database Access - UNSW Library. B-Com Web. Isotron Ethylene Oxide (ETO) Sterilisation. WHO Model List of Essential Medicines. 8946395. INN and Biologicals. Bq_innproposal201407.pdf. The Challenges in Manufacturing Biologics. Monoclonal Antibody Production [HD Animation]

Monoclonal Antibody Production. The Making of Protein Therapies. Quality use of blood products - Australian Prescriber. Big Data in Pharma. Nbt.3036.pdf. Quality by design for biopharmaceuticals : Article : Nature Biotechnology. Www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/UCM304305.pdf.

PQLI<sup>®</sup> Part 2: Product Realization using QbD, Illustrative Example. American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology. Pfizer Abstract The concepts described in ICH Q8-Q11, commonly referred to as Quality by Design (QbD), have also been applied to the development of analytical methods.

American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology

An overview of these concepts using the development of a reversed-phase liquid chromatography assay and related substances drug product method is provided. The benefits of applying QbD principles to analytical methods include identifying and minimizing sources of variability that may lead to poor method robustness and ensuring that the method meets its intended performance requirements throughout the product and method lifecycle. Introduction Figure 1. ShahNov2009.pdf. Pharmaceutical “Quality by Design” (QbD): An Introduction, Process Development and Applications. Quality means fitness for intended use.

Pharmaceutical “Quality by Design” (QbD): An Introduction, Process Development and Applications

Pharmaceutical quality refers to product free of contamination and reproducibly delivers the therapeutic benefit promised in the label to the consumer. The Quality of the pharmaceutical product can be evaluated by in vivo or in vitro performance tests. FCS4_1010_John_Berridge.pdf. UCM304305.pdf. Quality by Design : Design Space. Overview of pharmaceutical excipients used in tablets and capsules. The pharmaceutical industry is ever thirsty to satisfy patient’s therapeutical needs and apart from active ingredients, inactive excipients play a major role in formulation development.

Overview of pharmaceutical excipients used in tablets and capsules

Pharmaceutical excipients are substances other than the pharmacologically active drug or prodrug which are included in the manufacturing process or are contained in a finished pharmaceutical product dosage form. In addition to transporting the active drug to the site in the body where the drug is intended to exert its action, excipients play an important part in the manufacturing process.

They may also be important for keeping the drug from being released too early in the assimilation process in places where it could damage tender tissue and create gastric irritation or stomach upset. Others help the drug to disintegrate into particles small enough to reach the blood stream more quickly and still others protect the product's stability so it will be at maximum effectiveness at time of use.

Rutesh H. 12F.pdf. International Society for Pharmaceutical Engineering. European Medicines Agency publishes booklet on European regulatory system for medicines. Promoting pharmaceutical science. Pharmaceutical science in the UK has a long and excellent record of medicines research and development, being at the forefront of many major advances in modern medicines and their use.

Promoting pharmaceutical science

The launch of 'New Medicines, Better Medicines, Better Use of Medicines' The guide, New Medicines, Better Medicines, Better Use of Medicines, developed by the Society’s Pharmaceutical Science Expert Advisory Panel, summarises the important role pharmacists and pharmaceutical scientists have played and continue to play in the development and use of medicines. Insight into New Drug Approvals in ICH Countries 2004-2013. The Centre for Innovation in Regulatory Science – CIRS recently published R&D Briefing 54, which looks specifically at trends in the number of New Active Substance (NAS) approval numbers and approval times across the following agencies’ processes: European Centralised, US FDA and Japananese PMDA.

Insight into New Drug Approvals in ICH Countries 2004-2013

Approvals are often a measure of the pharmaceutical industry’s output and are, along with approval times, used as markers of the regulatory environment. Observations for 2013 and over the last decade are: Principles and Practice of Drug Development. The Pharmaceutical Collection. Novartis. Ocw.uci.edu/cat/oo/getPage.php?course=OC0706041&lesson=1&topic=1&page=1. Protein Lounge - Biology Animations, Scientific Animations. Www.webcampus.stevens.edu/uploadedFiles/020_Degree_Programs/_pdf/PME530_Syllabus.pdf.

Revolutionising Biomedical Education. How It's Made Pills. Www.abpischools.org.uk/res/coResourceImport/resources04/manufacturing/index.cfm. Pharmaceutical Institute - Understanding Pharma™ - Drug Development.